Printer Friendly

Flamel Technologies' Q3 fiscal 2014 net loss widens to USD10.0m.

M2 EQUITYBITES-November 3, 2014-Flamel Technologies' Q3 fiscal 2014 net loss widens to USD10.0m

(C)2014 M2 COMMUNICATIONS http://www.m2.com

Drug delivery company Flamel Technologies (NASDAQ:FLML) disclosed on Friday its net loss of USD10.0m for the third quarter of fiscal year 2014.

This is compared with net loss of USD6.4m in the year-ago period.

Earnings per share (both basic and diluted) of USD0.26 were recorded in the third quarter of 2014 versus earnings per share (both basic and diluted) of USD0.25 in the third quarter of 2013.

Total revenues of USD7.0m were collected during the third quarter of 2014, up USD1.4m in revenues over the prior year period.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2014 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Article Type:Financial report
Date:Nov 3, 2014
Words:128
Previous Article:Methanex files up to offering of USD750m in short form base shelf prospectus.
Next Article:PSPI unveils deal for disposal of German assets.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters